Stephan Dietrich A

CIK 00017745881 companyPITTSBURGH, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001774588

Recent Transactions

21 trades

Exercise/Conversion
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2023-08-02−93,234→ 0 total
Exercise/Conversion
NeuBase Therapeutics, Inc.
Common Stock
2023-08-02$0.02/sh+93,234→ 93,234 total
Award
NeuBase Therapeutics, Inc.
Common stock
2023-03-16+153,000→ 153,000 total
Exercise/Conversion
NeuBase Therapeutics, Inc.
Common Stock
2023-02-13+655,000→ 1,471,775 total
Exercise/Conversion
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2023-02-13−655,000→ 1,864,680 total
Exercise/Conversion
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2022-09-28$0.00/sh−750,000→ 2,519,680 total
Exercise/Conversion
NeuBase Therapeutics, Inc.
Common Stock
2022-09-28$0.00/sh+750,000→ 816,775 total
Award
NeuBase Therapeutics, Inc.
Employee Stock option (right to buy)
2022-01-24+306,000→ 306,000 total
Exercise/Conversion
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2021-12-31$0.00/sh−42,250→ 3,269,680 total
Exercise/Conversion
NeuBase Therapeutics, Inc.
Common Stock
2021-12-31$0.00/sh+42,250→ 66,775 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2021-04-26$5.00/sh+12,000→ 24,525 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2020-12-29+164,925→ 164,925 total
Gift
NeuBase Therapeutics, Inc.
Common Stock
2020-12-01−1,273,820→ 1,273,819 total
Gift
NeuBase Therapeutics, Inc.
Common Stock
2020-12-01−1,273,819→ 2,547,639 total
Gift
NeuBase Therapeutics, Inc.
Common Stock
2020-11-30−1,273,819→ 2,547,639 total
Gift
NeuBase Therapeutics, Inc.
Common Stock
2020-11-23−2,547,639→ 2,547,639 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2020-06-09$7.73/sh+1,275→ 12,525 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2020-05-21$8.09/sh+1,250→ 11,250 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2020-04-30$6.00/sh+10,000→ 10,000 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2019-07-12+3,311,930→ 3,311,930 total
Award
NeuBase Therapeutics, Inc.
Common stock
2019-07-12+2,547,639→ 2,547,639 total

Companies

NeuBase Therapeutics, Inc.
Director, President and CEO, 10% Owner

Recent Filings

Address

C/O 700 TECHNOLOGY DRIVE, THIRD FLOOR

PITTSBURGH, PA, 15219

View on SEC.gov